CORRECTED: Affymetrix Reports Q1 Revenue Rise

genomeweb
360dx

CORRECTED: Affymetrix Reports Q1 Revenue Rise

Apr 24, 2002

This article has been corrected from a previous version that misstated the company's cash holdings.

To read the full story....

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

Illumina Launches $650M Senior Notes Offering
Bionano Genomics Reduces Size of Proposed IPO
Natera Partners With Fox Chase to Evaluate ctDNA Cancer Assay
Chinese FDA Approves Novogene CDx Test for NSCLC Therapies
UPDATE: GeneNews Posts 88 Percent Decline in Q2 Revenues; Inks Liquid Biopsy Alliance With LifeX
Biocept Q2 Revenues Fall 37 Percent

The Scan

Testing Less Likely

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three for Immunotherapy

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

Cancer-Fighting Zombies

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.

This Week in Genome Research

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Main menu